{"organizations": [], "uuid": "9aaebb545bddb1b08e144c6294b135f7656dfc83", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180111.html", "section_title": "Archive News &amp; Video for Thursday, 11 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-hemispherx-biopharma-says-new-deve/brief-hemispherx-biopharma-says-new-development-to-provide-consistent-enzyme-product-uninterrupted-production-of-ampligen-idUSFWN1P60FZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Hemispherx Biopharma says ‍New Development to Provide Consistent Enzyme Product, Uninterrupted Production Of Ampligen", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.108, "site_type": "news", "published": "2018-01-11T21:38:00.000+02:00", "replies_count": 0, "uuid": "9aaebb545bddb1b08e144c6294b135f7656dfc83"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-hemispherx-biopharma-says-new-deve/brief-hemispherx-biopharma-says-new-development-to-provide-consistent-enzyme-product-uninterrupted-production-of-ampligen-idUSFWN1P60FZ", "ord_in_thread": 0, "title": "BRIEF-Hemispherx Biopharma says ‍New Development to Provide Consistent Enzyme Product, Uninterrupted Production Of Ampligen", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "hemispherx biopharma inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-hemispherx biopharma", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - Hemispherx Biopharma Inc:\n* HEMISPHERX BIOPHARMA - ‍NEW DEVELOPMENT CAN PROVIDE CONSISTENT ENZYME PRODUCT,UNINTERRUPTED PRODUCTION OF AMPLIGEN,IN LONG RUN,REDUCE PRODUCTION COSTS​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-11T21:38:00.000+02:00", "crawled": "2018-01-12T18:34:33.004+02:00", "highlightTitle": ""}